Canopy Growth has been slashing costs, but the business remains unprofitable. Its biggest backer, Constellation Brands, looks to be distancing itself from the cannabis producer.
Benchmark analysts on Monday reiterated their sell rating on Canopy Growth Corp. as it burns cash at a rate that's more “intense than a midnight blaze” while TD Cowen sounded a more positive tone
Quarterly results from the U.S.'s largest cannabis company Curaleaf Holdings Inc. and Canada's Canopy Growth Corp. missed analyst estimates, while Ascend Wellness managed to beat forecasts.
Canopy Growth Corporation (TSX:WEED, NYSE:CGC) after Thursday's close announced that its second quarter 2024 adjusted core loss improved to C$11.9 million from a loss of C$56.4 million a year earlier
Canopy Growth Corporation (NASDAQ:CGC ) Q2 2024 Results Conference Call November 9, 2023 5:30 PM ET Company Participants Tyler Burns - Director, IR David Klein - CEO Judy Hong - CFO Conference Call Pa
Canopy Growth has been trimming costs as it shifts towards an "asset-light" operating model. Tilray has been acquiring beverage companies and brands in an effort to further diversify its operations.

Top Canadian Cannabis Stocks For Q4 2023

02:30pm, Wednesday, 08'th Nov 2023
The cannabis industry in Canada continues to be a hub of financial opportunities, drawing in both seasoned investors and novices. The industry's unrelenting expansion has been nothing short of extraor
The rollercoaster ride of the cannabis market has left many in the investing world dazed and confused. The sector's volatility is marked by winds of optimism followed by spells of disappointment.
Canopy Growth's lack of progress with improving its free cash burn forms a core headwind to its prospects as a public company. CGC's cash position is declining as avenues to raise cash, whilst still b
Cannabis companies are preparing to release their 2023 third-quarter earnings. If companies can show positive results we may see one final rebound before the start of 2024. In the past when people saw
Canopy Growth's hopes hinge on federal marijuana legalization in the U.S. Federal legalization could still be years away, and there's no guarantee that it ever will happen. Canopy Growth continues to
In the second quarter of fiscal 2024, Canopy Growth (CGS) is expected to demonstrate an improved performance in the Canadian cannabis business.
Investors and traders in the Canadian cannabis market are closely monitoring the leading Canadian cannabis stocks as November draws near. Recent years have seen a substantial increase in the legalizat
The current activity in the U.S. House of Representatives doesn't benefit cannabis companies. While the chamber lacks a Speaker, it can't conduct any business -- which includes debating and voting on
As we enter the fourth quarter of 2023 the cannabis sector is progressing into the future. More companies are working on various ventures and developing new products. Not only that there is the contin
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE